Inactive Instrument

Dthera Sciences

Equities

DTHR

US2333623005

Advanced Medical Equipment & Technology

Dthera Sciences announced that it expects to receive $1.2439 million in funding

November 16, 2016

Dthera Sciences (OTCPK:DTHR) announced that it will receive $1,750,000 in funding on November 17, 2016. The company will issue common shares in the transaction. The minimum investment accepted from any outside investor is $5,000. The company will issue securities pursuant to exemption provided under Regulation D.

Latest news about Dthera Sciences

Telememory Holding Corp acquired Dthera Sciences.	22-05-10	CI
Dthera Sciences Enters into an Exclusivity Agreement with Respect to the Company’S Lead Product, DTHR-ALZ	19-02-22	CI
Dthera Sciences Reports Earnings Results for the Third Quarter Ended September 30, 2018	18-11-14	CI
Dthera Sciences Appoints Amir Kalali to Board of Directors and Chairman of Scientific Advisory Board	18-10-30	CI
Dthera Sciences will Change its Ticker to DTHR.D from DTHR	18-09-25	CI
Dthera Sciences announced that it has received $1 million in funding from Ionic Ventures, LLC	18-09-20	CI
Dthera Sciences announced that it expects to receive $0.4 million in funding from RSJ Private Equity Uzavreny Investicni Fond a.s.	18-09-16	CI
Dthera Sciences announced that it expects to receive $0.25 million in funding from Wade Capital Corporation	18-09-13	CI
FDA Grants Breakthrough Device Designation to Dthera Sciences's DTHR-ALZ	18-08-23	CI
Dthera Sciences Launches ReminX	18-08-06	CI
Dthera Sciences announced that it has received $2.55125 million in funding	18-07-22	CI
Dthera Sciences Appoints Steve R. Martin as Director to the Board	18-04-13	CI
Dthera Sciences Reports Earnings Results for the Year Ended December 31, 2017	18-04-03	CI
Dthera Sciences announced a financing transaction	17-11-01	CI
CurePSP & Dthera Sciences Announces Initial Positive Results of Pilot Program	17-10-04	CI
Dthera Sciences announced that it has received $0.975 million in funding	17-09-20	CI
Dthera Sciences announced that it has received $0.09 million in funding	17-08-31	CI
Dthera Sciences announced a financing transaction	17-08-25	CI
Dthera Sciences announced that it expects to receive $0.975 million in funding	17-07-18	CI
Dthera Sciences announced that it has received $1.2439 million in funding	17-04-16	CI
Dthera Sciences will Change its Ticker to DTHR from KNMX.D	16-11-29	CI
Dthera Sciences Approves Fiscal Year Change from June 30 Year-End to Calendar Year-End of December 31	16-11-17	CI
Dthera Sciences announced that it expects to receive $1.2439 million in funding	16-11-16	CI
EveryStory, Inc. completed the acquisition of Knowledge Machine International, Inc. in a reverse merger transaction.	16-09-20	CI
EveryStory, Inc. entered into an acquisition and share Exchange agreement to acquire Knowledge Machine International, Inc. in a reverse merger transaction.	16-07-05	CI

Chart Dthera Sciences

Duration

Period

More charts

Company Profile

Dthera Sciences, formerly Knowledge Machine International, Inc., is a digital health company. The Company is focused on supporting Alzheimer's and Dementia patients catering to the senior living market. The Company offers a product, EveryStory. EveryStory uses a chat system (called Rachel) to directly engage with family members. Through EveryStory, users can send various photos and record audio. EveryStory is a closed system in which the people who are authorized to be within the residents group can add stories or audio.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology